New pharma and biotech manufacturing facilities and expansions announced worldwide for 2024

[Adobe Stock]

The pharma and biotech sectors continue to rapidly transform in response to rising demand for innovative therapies. While less fortunate players are shedding jobs, in 2024, major players like AbbVie, AGC Biologics, and Amgen are investing heavily in new manufacturing facilities worldwide, from Singapore to Japan and the U.S. Companies expanding in North Carolina, Ohio, and Iceland signal a push to make innovative medicines and advanced therapies more accessible globally.

The map below shows select new plant openings and expansions announced in 2024, with 8 in North America and 15 in other regions

North America United States Amgen opened a new AI-enabled biomanufacturing facility in New Albany, Ohio, employing roughly 400 people. The $365 million investment features automation, AI, and data-driven manufacturing processes. Amgen also plans to advance drug discovery using AI models at deC…
Read more
  • 0

Pharma manufacturing sees wave of investments in Europe

[Adobe Stock]

Over the past three months, the pharma sector has seen a string of investments in manufacturing facilities, especially in Europe. While the European economy lost momentum in 2023 owing to a high cost of living, weak external demand, and monetary tightening, the prospects for growth remain stronger with the EU GDP growth forecast to improve to 1.3% in 2024, according to the European Commission. As economic prospects improve in 2024, major pharma companies are doubling down on investments in European manufacturing infrastructure and jobs to meet strong global demand. While the sector regains momentum, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has expressed concerns about a proposed overhaul of pharma rules from the European Commission, which it worries could harm future investments in the region. For the time being, major pharma companies including Novo Nordisk, Eli Lilly…
Read more
  • 0